TS-SARS-CoV-2 Antibody Durability-990x120

Event Overview

COVID-19 vaccine development depends on identifying potent neutralizing antibodies. Recent research studies suggest that neutralizing antibodies found in the blood of recovered COVID-19 patients decay rapidly and the level of antibody protection may correlate with infection severity. In this webinar brought to you by The Scientist, scientists studying the SARS-CoV-2 immune response will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.

Topics to be covered
  • Assessing antibodies to SARS-CoV-2 in the saliva of COVID-19 patients
  • Examining immune memory formation and persistence in individuals that recovered from mild COVID-19
Monday, October 26, 2020
2:30 - 4:00 PM, Eastern Time


Jennifer Gommerman, PhD
Professor, Department of Immunology Biology
Canada Research Chair in Tissue Specific Immunity
Associate Chair, Graduate Studies, Department of Immunology
University of Toronto

Marion Pepper, PhD
Associate Professor, Department of Immunology
University of Washington







Register Now

Optimizing Lab Ultrafiltration Workflows: From Molecule Separation to Diagnostics

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.